The Efficacy of Add-on Telbivudine Versus Switching to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients With Poor Responses to Adefovir.
Author: Wei X, Fan C, Zhou Y, Kang W, Wang J, Sun L, Wang L, Peng M, Lian J, Jia Z, Hao C.
Estimated Glomerular Filtration Rate Increases in Chronic Hepatitis B Patients Treated With Telbivudine Monotherapy and Combination Treatment.
Author: Jiang L, Hu S, He M, Tian D.
Expression of MicroRNA-155 is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Patients.
Author: Yu SL, Deng H, Li XH, Huang YX, Xie DY, Gao ZL.
A Patient With Primary Biliary Cirrhosis Accompanied by Wilson's Disease.
Author: Zhao SX, Zhang YG, Wang RQ, Li WC, Kong LB, Kong L, Nan YM.
英文介紹
Hepatitis Monthly雜志英文介紹
Hepatitis Monthly is a clinical journal which is informative to all practitioners like gastroenterologists, hepatologists and infectious disease specialists and internists. This authoritative clinical journal was founded by Professor Seyed-Moayed Alavian in 2002. The Journal context is devoted to the particular compilation of the latest worldwide and interdisciplinary approach and findings including original manuscripts, meta-analyses and reviews, health economic papers, debates and consensus statements of the clinical relevance of hepatological field especially liver diseases. In addition, consensus evidential reports not only highlight the new observations, original research, and results accompanied by innovative treatments and all the other relevant topics but also include highlighting disease mechanisms or important clinical observations and letters on articles published in the journal.